- | Country : -
- | organs : -
- | Specialty : -
Extract
• To demonstrate the superiority in overall survival of ODM-201 in addition to standard androgen deprivation therapy (ADT) and docetaxel over placebo in addition to standard ADT and docetaxel
Inclusion criteria
- Metastatic Hormone-sensitive Prostate Cancer (mHSPC)